| Family Home Health Services, Inc 2171 Executive Drive, Addison, IL, 60101 | |
| (630) 317-3300 |
News Archive
The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
At the 51st ENC, Bruker launches its new Ascend™ series of compact, high field NMR magnets to make high-field NMR even more powerful, and at the same time more convenient and accessible for numerous NMR laboratories. This new magnet line combines the key advantages of Bruker's well-established UltraShield™ Plus magnets, with further innovations for superior performance and greater convenience.
The White House criticized the findings of a report by a conservative economist who serves as a trustee overseeing Medicare and Social Security finances, saying they represented a partisan analysis.
GeneTex, a leading manufacturer of antibodies and antibody-related reagents, is set to launch a new antibody against phosphorylated Histone H3.
Researchers at the University of North Carolina at Chapel Hill and colleagues have developed the first genetic strain of mice that can be infected with Ebola and display symptoms similar to those that humans experience.
› Verified 8 days ago
| Name | Family Home Health Services, Inc |
|---|---|
| Location | 2171 Executive Drive, Addison, Illinois |
| Hospice ID | 141622 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 250 |
News Archive
The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
At the 51st ENC, Bruker launches its new Ascend™ series of compact, high field NMR magnets to make high-field NMR even more powerful, and at the same time more convenient and accessible for numerous NMR laboratories. This new magnet line combines the key advantages of Bruker's well-established UltraShield™ Plus magnets, with further innovations for superior performance and greater convenience.
The White House criticized the findings of a report by a conservative economist who serves as a trustee overseeing Medicare and Social Security finances, saying they represented a partisan analysis.
GeneTex, a leading manufacturer of antibodies and antibody-related reagents, is set to launch a new antibody against phosphorylated Histone H3.
Researchers at the University of North Carolina at Chapel Hill and colleagues have developed the first genetic strain of mice that can be infected with Ebola and display symptoms similar to those that humans experience.
› Verified 8 days ago
| NPI Number | 1982657292 |
| Organization Name | Family Home Health Services, Inc. |
| Address | 2171 W Executive Dr Addison, Illinois, 60101 |
| Phone Number | (630)317-3300 |
News Archive
The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
At the 51st ENC, Bruker launches its new Ascend™ series of compact, high field NMR magnets to make high-field NMR even more powerful, and at the same time more convenient and accessible for numerous NMR laboratories. This new magnet line combines the key advantages of Bruker's well-established UltraShield™ Plus magnets, with further innovations for superior performance and greater convenience.
The White House criticized the findings of a report by a conservative economist who serves as a trustee overseeing Medicare and Social Security finances, saying they represented a partisan analysis.
GeneTex, a leading manufacturer of antibodies and antibody-related reagents, is set to launch a new antibody against phosphorylated Histone H3.
Researchers at the University of North Carolina at Chapel Hill and colleagues have developed the first genetic strain of mice that can be infected with Ebola and display symptoms similar to those that humans experience.
› Verified 8 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 96.9 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 89.5 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 96.5 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 54.8 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.4 | 97.3 |
| Patients who got timely treatment for shortness of breath | 97.1 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 88.7 | 93.3 |
News Archive
The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
At the 51st ENC, Bruker launches its new Ascend™ series of compact, high field NMR magnets to make high-field NMR even more powerful, and at the same time more convenient and accessible for numerous NMR laboratories. This new magnet line combines the key advantages of Bruker's well-established UltraShield™ Plus magnets, with further innovations for superior performance and greater convenience.
The White House criticized the findings of a report by a conservative economist who serves as a trustee overseeing Medicare and Social Security finances, saying they represented a partisan analysis.
GeneTex, a leading manufacturer of antibodies and antibody-related reagents, is set to launch a new antibody against phosphorylated Histone H3.
Researchers at the University of North Carolina at Chapel Hill and colleagues have developed the first genetic strain of mice that can be infected with Ebola and display symptoms similar to those that humans experience.
› Verified 8 days ago
| Home Health Aides | 8 |
| Counselors | 2.5 |
| Homemakers | 8 |
| Licensed Practical or Vocational Nurses | 0.5 |
| Medical Social Workers | 4.5 |
| Physicians | 2 |
| Registered Nurses | 23 |
| Other Personnel | 1.5 |
| Total Employees | 50 |
|---|
News Archive
The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.
At the 51st ENC, Bruker launches its new Ascend™ series of compact, high field NMR magnets to make high-field NMR even more powerful, and at the same time more convenient and accessible for numerous NMR laboratories. This new magnet line combines the key advantages of Bruker's well-established UltraShield™ Plus magnets, with further innovations for superior performance and greater convenience.
The White House criticized the findings of a report by a conservative economist who serves as a trustee overseeing Medicare and Social Security finances, saying they represented a partisan analysis.
GeneTex, a leading manufacturer of antibodies and antibody-related reagents, is set to launch a new antibody against phosphorylated Histone H3.
Researchers at the University of North Carolina at Chapel Hill and colleagues have developed the first genetic strain of mice that can be infected with Ebola and display symptoms similar to those that humans experience.
› Verified 8 days ago
| Family Home Health Services, Inc Location: 2171 Executive Drive, Addison, Illinois, 60101 Phone: (630) 317-3300 |